Skip to main content

Table 1 Prevalence of multimorbidity by country, age group and gender among people aged 50 and over

From: Trends of multimorbidity in 15 European countries: a population-based study in community-dwelling adults aged 50 and over

  Years Period 95% CI 50–59 95% CI 60–69 95% CI 70–79 95% CI 80+ 95% CI
AAPC Lower Upper AAPC Lower Upper AAPC Lower Upper AAPC Lower Upper AAPC Lower Upper
Men
 Austria 2004–2017 2.3a 0.9 3.7 2.4a 0.7 4.2 1.9a 0.3 3.6 2.2a 1.8 2.6 3.6a 0.8 6.6
 Belgium 2004–2017 1.7a 0.4 2.9 2.7a 0.1 5.3 2.2a 1.7 2.6 1.8a 0.5 3.1 0.5 −0.6 1.6
 Czech Republic 2007–2017 2.7a 2.2 3.3 4.6a 2.7 6.6 1.4a 0.1 2.8 3.3a 2.2 4.5 2.9a 1.8 4.0
 Denmark 2004–2017 0.9 −0.0 1.8 0.9 −0.9 2.7 1.2 −0.6 3.1 1.4a 0.2 2.7 2.2 −1.0 5.4
 Estonia 2011–2017 −2.6 −9.1 4.3 −4.8a −8.0 −1.4 − 1.7 − 14.3 12.7 −3.5 − 10.0 3.5 − 1.3 −9.7 8.0
 France 2004–2017 1.0a 0.1 1.9 0.6 −2.7 4.1 −0.3 −1.3 0.7 1.5 − 0.7 3.8 0.9 −0.8 2.7
 Germany 2004–2017 6.9a 1.8 12.3 5.0a 0.4 9.9 3.0a 0.3 5.9 2.6a 1.3 3.9 0.5 −0.1 1.1
 Netherlands 2004–2017 2.9a 0.2 5.8 4,8 −3,8 14,3 0,4 −1,1 1,9 3,5 −1,5 8,8 4,3 −0,4 9,3
 Italy 2004–2017 −1.6 −3.3 0.1 −4.4a −6.4 −2.3 − 3.2a −4.9 − 1.4 − 0.2 − 1.4 1.1 2.4a 1.5 3.3
 Poland 2007–2017 1.2 −1.0 3.4 −0.5 −4,1 3.2 −0.0 − 1.4 1.4 2.3a 0.3 4.3 4.4a 0.2 8.9
 Portugal 2011–2017 −2.3 −8.0 3.8 − 2.1 −16.9 15.2 −4.1 −11.4 3.7 1.0 −5.3 7.7 −0.0 −16.2 19.2
 Slovenia 2011–2017 2.1 −2.2 6.6 0.9 −4.1 6.1 3.8 −7.9 17.0 3.5 −1.5 8.9 5.6 −2.8 14.7
 Spain 2004–2017 2.0a 0.7 3.4 5.3a 2.2 8.6 1.8a 0.0 3.7 2.7a 0.9 4.5 3.1a 1.6 4.6
 Sweden 2004–2017 −0.0 −1.2 1.1 1.3 −2.6 5.4 −1.0 −3.1 1.2 −0.4 −1.4 0.6 −0.2 −2.6 2.2
 Switzerland 2004–2017 2.7a 0.9 4.6 1.6 −0.2 3.4 1.3 −1.2 4.0 2.9a 1.1 4.3 5.4a 3.2 7.7
Women
 Austria 2004–2017 2.2a 0.9 3.5 −1.3 −6.5 4.3 0.3 −1.2 1.9 3.3a 1.5 5.1 4.0a 2.2 5.8
 Belgium 2004–2017 1.5a 0.4 2.7 1.7 −1.4 4.9 0.9 −0.5 2.3 1.0a 0.2 1.8 0.7 −0.2 1.7
 Czech Republic 2007–2017 2.6a 2.1 3.0 4.0a 2.3 5.7 1.4a 0.3 2.5 2.1a 1.4 2.8 2.0 −0.1 4.1
 Denmark 2004–2017 0.8 −0.1 1.7 −1.3a −2.1 −0.4 0.6 −1.3 2.4 0.3 −1.0 1.5 0.8 −1.1 2.8
 Estonia 2011–2017 −2.4 −8.4 3.9 −4.2 − 10.2 2.3 −3.2 − 7.0 0.8 −1.9 −7.6 4.2 −0.6 − 4.2 3.2
 France 2004–2017 0.9a 0.2 1.7 −1.8 −4.2 0.7 1.5a 0.9 2.0 0.8 −0.5 2.1 1.6a 0.4 2.9
 Germany 2004–2017 3.2a 2.0 4.4 5.0a 3.1 7.0 2.3a 1.3 3.3 3.5a 1.9 5.1 2.1a 1.4 2.8
 Netherlands 2004–2017 2.7 −0.0 5.6 0,1 −2,5 2,8 1,2 −3,3 6 3,1 −1 7,3 4,2 −5,4 14,8
 Italy 2004–2017 − 1.2 −2.7 0.3 − 5.0a −7.1 − 3.0 − 2.5a −4.6 −0.3 − 0.9 − 2.4 0.6 0.9 − 0.8 2.5
 Poland 2007–2017 1.1 − 1.1 3.3 1.2 −3.6 6.2 0.1 −1.6 1.8 0.5 −0.7 1.8 3.0 −0.5 6.7
 Portugal 2011–2017 −2.1 −7.6 3.8 −3.3 −8.0 1.7 −4.0 −16.9 10.9 −1.6 − 11.9 9.8 1.0 −2.9 5.1
 Slovenia 2011–2017 2.1 −2.0 6.4 −4.5a −7,8 −1,1 −0,5 −6,6 6 3,6 −3,9 11,8 4,9 −2,6 13
 Spain 2004–2017 1.9a 0.7 3.1 −0.2 −3.0 2.7 −0.4 −1.9 1.1 1.2a 0.4 2.0 3.1a 1.4 4.9
 Sweden 2004–2017 −0.1 −1.2 1.1 −1.1 −4.1 2.0 0.2 −1.4 1.8 0.2 −1.1 1.4 −0.6 −2.6 1.4
 Switzerland 2004–2017 2.6a 1.0 4.4 3.9a 0.0 8.0 4.1a 0.8 7.5 0.6 −0.6 1.9 3.5 −0.5 7.5
  1. aStatistically significant (p < 0.05)
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us